Open navigation
Search
Search
All expertise
Explore our breadth of expertise.
International Desks
Helping you access overseas markets with support from our country and region-specific experts
Sectors View all
Practice Areas View all
Offices
Discover the scope of our presence in the jurisdiction.
Global Reach
Learn about our capabilities beyond borders.
CMS China
All insights
Leverage our expert analysis, intelligence and thought leadership for your strategic advantage.
Personalised updates
Receive tailored insights and intelligence that apply directly to your business.
Topics in focus View all
Insights by type
CMS News
Stay up to date with our growth, evolution and our many successes.
Contact us
For all general enquiries.
About CMS
CMS Careers

Select your region

International Europe Africa Asia-Pacific The Americas Middle East
English 简体中文
Publication

China's drug price reforms

Much of the same?

01 Jul 2015 China 1 min read

On this page

    Interviewed by China Law and Practice, CMS, China Lifesciences team commented on China's latest drug pricing reform. This article was firstly published on 12 June, 2015.

    Please access the source for more detailed information.

    More insights
    Life Sciences & Healthcare

    Explore more

    Expert Guide International

    Pharmaceutical advertising regulation and medical device advertising in China

    17 min read
    Event China

    IP Insights webinar series 2026

    03 Jun 2026
    Newsletter China

    China Tightens Obligations of CMOs in Drug Contract Manufacturing

    11 Mar 2026 1 min read
    Back to top Back to top
    If you want to use third party tools, please enable personalisation cookies as part of your cookie preferences. You can change this setting at any time via the button below or in our Cookie Notice.